Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type β-lactamase

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1130-1133

  Kang, Cheol In ^a   Pai, Hyunjoo ^b   Kim, Sung Han ^a   Kim, Hong Bin ^a   Kim, Eui Chong ^a,c   Oh, Myoung Don ^a,c   Choe, Kang Won ^a,c  

^a Seoul National University   (South Korea)

^b Hanyang University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

lactam resistance; Cephalosporins; K. pneumoniae

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; IMIPENEM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; ENZYME SYNTHESIS; IN VITRO STUDY; INOCULATION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 12344334529     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh462     Document Type: Article

References (10)

1. Philippon, A. & Jacoby, G. A. (2002). Plasmid-determined AmpC-type β-lactamases. Antimicrobial Agents and Chemotherapy 46, 1-11.
2. Yan, J. J., Ko, W. C., Jung, Y. C. et al. (2002). Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. Journal of Clinical Microbiology 40, 3121-6.
3. Coudron, P. E., Hanson, N. D. & Climo, M. W. (2003). Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases. Journal of Clinical Microbiology 41, 772-7.
4. Thomson, K. S. & Moland, E. S. (2001). Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 45, 3548-54.
5. Thauvin-Eliopoulos, C., Tripodi, M.-F., Moellering, R. C. et al. (1997). Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum β-lactamase-producing strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 41, 1053-7.
6. Paterson, D. L., Ko, W.-C., Gottberg, A. V. et al. (2001). Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. Journal of Clinical Microbiology 39, 2206-12.
7. Livermore, D. M. (1998). β-Lactamase-mediated resistance and opportunities for its control. Journal of Antimicrobial Chemotherapy 41, Suppl. D, 25-41.
8. Pai, H., Kang, C. I., Byeon, J. H. et al. (2004). Epidemiology and clinical features of bloodstream infections caused by AmpC type β-lactamase-producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 48, 3720-8.
9. National Committee for Clinical Laboratory Standards. (2003). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - Sixth Edition: Approved standard M7-A6. NCCLS, Wayne, PA, USA.
10. Rice, L. B., Yao, J. D. C., Klimm, K. et al. (1991). Efficacy of different β-lactams against an extended-spectrum β-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrobial Agents and Chemotherapy 35, 1243-4.